ReviewCureus2025

Empagliflozin Treatment for Non-alcoholic Fatty Liver Disease in Type 2 Diabetes Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Loiy Naser Alsarkhi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.